Systematic Intervention to Improve Sexual Dysfunction

Not Applicable

Not yet recruiting

• Conditions: Breast Cancer Female; Localized Cancer

• Registration Number: NCT06583460
• Lead Sponsor: Center Eugene Marquis

Brief Summary

The aim of this clinical trial is to compare the benefit of early, systematic, multidisciplinary oncosexological care versus on-demand care on the sexual health of women with breast cancer.

Detailed Description

The aim of the study is to evaluate the effectiveness of early, systematized oncosexology care on perceived sexual health at 18 months, compared with oncosexology care on demand.

All included patients are evaluated at Baseline and M18 following initiation of antineoplastic treatments associated with surgery. Patients who accepted additional oncosexological care were also assessed at M4, M8 and M12. The content of support care is detailed in section "arms and interventions".

Oncosexology consultations with the sexologist and the medical support care of any organic disorders remain accessible to all patients, on request, including the group of patients who do not wish to participate in early and systematic oncosexology care.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2024-06
• Study First Submitted: 2024-08-06
• Study First Submitted QC: 2024-09-02
• Study First Posted: 2024-09-04
• Last Update Submitted: 2024-11-04
• Last Update Posted: 2024-11-06
• Study Start: 2024-11-25
• Primary Completion: 2028-01-15
• Study Completion: 2028-01-15

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Women ≥ 18 years (menopausal or not),
• Localized breast cancer with or without lymph node involvement,
• Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
• Patient affiliated or benefiting from the social security system,
• Patient informed and informed consent signed.

Read More

Exclusion Criteria

• History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
• Pregnant or breast-feeding women,
• Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
• Patients unable to comply with the study schedule for social, medical or psychological reasons.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Sexual satisfaction	Measured at baseline and at 18 months following initiation of treatment and surgical.	Sexual satisfaction score measured by self-questionnaire using the EORTC Quality of Life Questionnaire Sexual Health scale (EORTC QLQ-SH22).

Trial Locations

Locations (1)

Centre de Lutte contre le Cancer Eugène Marquis; 🇫🇷 Rennes, Bretagne, France